Premium
Myeloid markers should be undertaken in cases of CD56 positivity to exclude granulocytic sarcoma
Author(s) -
Kurata H.,
Okukubo M.,
Fukuda E.,
Ichihashi M.,
Ueda M.
Publication year - 2002
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1046/j.1365-2133.2002.48654.x
Subject(s) - pathology , sarcoma , myeloproliferative disorders , myeloid , myelodysplastic syndromes , medicine , bone marrow , leukemia , haematopoiesis , cancer research , biology , stem cell , immunology , genetics